Live Breaking News & Updates on Insider Activity At Vertex Pharmaceuticals

Stay updated with breaking news from Insider activity at vertex pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rhenman & Partners Asset Management AB Acquires 18,500 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Rhenman & Partners Asset Management AB grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,000 shares of the pharmaceutical company’s stock after purchasing an additional […] ....

Reshma Kewalramani , Charlesf Wagner Jr , Oppenheimer Co , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Quarter For Vertex Pharmaceuticals , Securities Inc , Kestra Private Wealth Services , Wolfe Research , Vertex Pharmaceuticals Profile , Vertex Pharmaceuticals Trading , Royal Bank , News Ratings For Vertex Pharmaceuticals Daily , Insider Activity At Vertex Pharmaceuticals , Exchange Commission , Summit Financial , Partners Asset Management , Free Report , Private Wealth Services , Pharmaceuticals Incorporated , Get Free Report , Visit Holdingschannel , Vertex Pharmaceuticals Daily ,

Provident Investment Management Inc. Sells 850 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Provident Investment Management Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,319 shares of the pharmaceutical company’s stock after selling 850 shares during the quarter. Vertex […] ....

Brucei Sachs , William Blair , News Ratings For Vertex Pharmaceuticals Daily , Securities Exchange Commission , Vertex Pharmaceuticals Incorporated , Provident Investment Management Inc , Vertex Pharmaceuticals Stock Down , Exchange Commission , Quarter For Vertex Pharmaceuticals , Vertex Pharmaceuticals Company Profile , Vertex Pharmaceuticals , Wolfe Research , Vanguard Group Inc , Northern Trust Corp , Insider Activity At Vertex Pharmaceuticals , Wells Fargo Company , Jennison Associates , Morgan Stanley , Norges Bank , Provident Investment Management , Free Report , Investment Management , Trust Corp , Pharmaceuticals Stock Down , Pharmaceuticals Incorporated , Get Free Report ,

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-four research firms that are currently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and fifteen have issued a […] ....

Sanfordc Bernstein , Brucei Sachs , Robertw Baird , Piper Sandler , Johnson Financial Group Inc , Vertex Pharmaceuticals , Nicholas Hoffman Company , Analyst Recommendations For Vertex Pharmaceuticals , Arthurm Cohen Associates , News Ratings For Vertex Pharmaceuticals Daily , Venturi Wealth Management , Hedge Funds Weigh In On Vertex Pharmaceuticals , Vertex Pharmaceuticals Company Profile , Vertex Pharmaceuticals Stock , Insider Activity At Vertex Pharmaceuticals , Vertex Pharmaceuticals Incorporated , Hohimer Wealth Management , Get Free Report , Marketbeat Ratings , Director Bruce , Wealth Management , Financial Group , Get Free , Pharmaceuticals Incorporated , Vertex Pharmaceuticals Daily ,

Portfolio Design Labs LLC Purchases New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Portfolio Design Labs LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,928 shares of the pharmaceutical company’s stock, valued at approximately $4,040,000. Vertex Pharmaceuticals accounts for […] ....

Sanfordc Bernstein , Robertw Baird , Brucei Sachs , Royal Bank , Needham Company , Exchange Commission , Jennison Associates , Northern Trust Corp , Insider Activity At Vertex Pharmaceuticals , News Ratings For Vertex Pharmaceuticals Daily , Norges Bank , Securities Exchange Commission , Portfolio Design Labs , Quarter For Vertex Pharmaceuticals , Vertex Pharmaceuticals Price Performance , Vertex Pharmaceuticals , Vertex Pharmaceuticals Incorporated , Free Report , Trust Corp , Director Bruce , Pharmaceuticals Incorporated , Get Free Report , Visit Holdingschannel , Vertex Pharmaceuticals Daily ,

Davis R M Inc. Buys New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Davis R M Inc. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 492 shares of the pharmaceutical company’s stock, valued at approximately $200,000. A number of other hedge funds and […] ....

Ourania Tatsis , Telos Capital Management Inc , Quarter For Vertex Pharmaceuticals , Davis Rm Inc , Vertex Pharmaceuticals Trading , Morgan Stanley , Vertex Pharmaceuticals , Sherbrooke Park Advisers , Investment Management , Insider Activity At Vertex Pharmaceuticals , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals Company Profile , News Ratings For Vertex Pharmaceuticals Daily , Needham Company , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Pharmaceuticals Incorporated , Get Free Report , Vertex Pharmaceuticals Daily ,